Application of Botulinum Toxin Type A in Salivary Glands in the Treatment of Drooling in Patients With Cerebral Palsy

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Allergan
Information provided by (Responsible Party):
Inma Bori i Fortuny, MD, Hospital Vall d'Hebron
ClinicalTrials.gov Identifier:
NCT01489904
First received: November 29, 2011
Last updated: October 28, 2012
Last verified: October 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: November 2012
  Primary Completion Date: November 2011 (Final data collection date for primary outcome measure)